Compare Stocks: TMCI, BVS, IRMD, and INMD

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BVS Bioventus	$14.26 +2.7%	$11.36	$6.26 ▼ $15.89	$1.17B	0.63	848,594 shs	506,036 shs
INMD InMode	$15.15 -0.3%	$14.68	$12.72 ▼ $16.74	$873.71M	1.89	488,667 shs	350,548 shs
IRMD iRadimed	$86.95 -0.2%	$94.17	$67.84 ▼ $107.90	$1.11B	0.9	134,674 shs	142,683 shs
TMCI Treace Medical Concepts	$4.79 +6.2%	$4.30	$1.17 ▼ $7.78	$293.31M	1.37	430,918 shs	245,387 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BVS Bioventus	+2.66%	+0.92%	+19.13%	+34.78%	+89.38%
INMD InMode	-0.33%	-1.05%	-0.85%	+8.99%	+3.41%
IRMD iRadimed	-0.24%	-6.00%	-7.12%	+0.59%	+22.46%
TMCI Treace Medical Concepts	+6.21%	+0.63%	+8.86%	+80.08%	-30.58%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BVS Bioventus	$14.26 +2.7%	$11.36	$6.26 ▼ $15.89	$1.17B	0.63	848,594 shs	506,036 shs
INMD InMode	$15.15 -0.3%	$14.68	$12.72 ▼ $16.74	$873.71M	1.89	488,667 shs	350,548 shs
IRMD iRadimed	$86.95 -0.2%	$94.17	$67.84 ▼ $107.90	$1.11B	0.9	134,674 shs	142,683 shs
TMCI Treace Medical Concepts	$4.79 +6.2%	$4.30	$1.17 ▼ $7.78	$293.31M	1.37	430,918 shs	245,387 shs

7 Energy Stocks to Buy and Hold Forever

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BVS Bioventus	+2.66%	+0.92%	+19.13%	+34.78%	+89.38%
INMD InMode	-0.33%	-1.05%	-0.85%	+8.99%	+3.41%
IRMD iRadimed	-0.24%	-6.00%	-7.12%	+0.59%	+22.46%
TMCI Treace Medical Concepts	+6.21%	+0.63%	+8.86%	+80.08%	-30.58%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BVS Bioventus	3.00	Buy	$16.25	13.96% Upside
INMD InMode	2.00	Hold	$16.00	5.61% Upside
IRMD iRadimed	2.80	Moderate Buy	$120.00	38.01% Upside
TMCI Treace Medical Concepts	1.86	Reduce	$5.17	7.93% Upside

Current Analyst Ratings Breakdown

Latest TMCI, BVS, IRMD, and INMD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/10/2026	TMCI Treace Medical Concepts	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$4.00 ➝ $5.00
8/6/2026	BVS Bioventus	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C) ➝ Hold (C+)
8/6/2026	INMD InMode	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D+)
8/6/2026	BVS Bioventus	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$18.00
8/6/2026	BVS Bioventus	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$18.00
8/3/2026	IRMD iRadimed	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy (B-) ➝ Hold (C+)
7/16/2026	TMCI Treace Medical Concepts	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$2.00 ➝ $4.00
6/30/2026	BVS Bioventus	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform	$14.00
6/16/2026	BVS Bioventus	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$15.00
6/15/2026	TMCI Treace Medical Concepts	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
6/2/2026	BVS Bioventus	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)

(Data available from 8/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BVS Bioventus	$568.09M	2.11	$1.31 per share	10.89	$3.30 per share	4.32
INMD InMode	$370.49M	2.35	$1.49 per share	10.19	$10.94 per share	1.38
IRMD iRadimed	$83.81M	13.27	$1.85 per share	46.89	$7.96 per share	10.92
TMCI Treace Medical Concepts	$212.69M	1.46	N/A	N/A	$1.04 per share	4.61

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BVS Bioventus	$22.73M	$0.77	18.52	16.02	1.77	9.36%	28.08%	9.82%	N/A
INMD InMode	$93.83M	$1.23	12.32	N/A	N/A	20.69%	11.99%	10.60%	10/28/2026 (Estimated)
IRMD iRadimed	$22.48M	$1.79	48.58	N/A	N/A	26.70%	23.45%	20.36%	11/2/2026 (Estimated)
TMCI Treace Medical Concepts	-$59M	-$0.93	N/A	N/A	N/A	-28.99%	-71.37%	-30.49%	N/A

Latest TMCI, BVS, IRMD, and INMD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2026	Q2 2026	TMCI Treace Medical Concepts	-$0.2980	-$0.24	+$0.0580	-$0.24	$44.02 million	$45.38 million
8/5/2026	Q2 2026	BVS Bioventus	$0.22	$0.22	N/A	$0.47	N/A	$153.21 million
8/5/2026	Q2 2026	INMD InMode	$0.3460	$0.35	+$0.0040	$0.29	$94.89 million	$95.59 million
7/31/2026	Q2 2026	IRMD iRadimed	$0.44	$0.46	+$0.02	$0.41	$20.35 million	$20.47 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BVS Bioventus	N/A	N/A	N/A	N/A	N/A
INMD InMode	N/A	N/A	N/A	N/A	N/A
IRMD iRadimed	$0.80	0.93%	N/A	44.69%	1 Years
TMCI Treace Medical Concepts	N/A	N/A	N/A	N/A	N/A

Latest TMCI, BVS, IRMD, and INMD Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/30/2026	IRMD iRadimed	quarterly	$0.20	0.93%	8/14/2026	8/14/2026	8/28/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BVS Bioventus	0.83	1.69	1.17
INMD InMode	N/A	8.18	7.28
IRMD iRadimed	N/A	9.46	8.13
TMCI Treace Medical Concepts	0.83	2.90	2.53

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BVS Bioventus	62.94%
INMD InMode	68.04%
IRMD iRadimed	92.34%
TMCI Treace Medical Concepts	84.08%

Insider Ownership

Company	Insider Ownership
BVS Bioventus	33.50%
INMD InMode	6.92%
IRMD iRadimed	34.60%
TMCI Treace Medical Concepts	23.42%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BVS Bioventus	1,200	84.09 million	55.55 million	N/A
INMD InMode	480	57.48 million	53.50 million	Optionable
IRMD iRadimed	110	12.79 million	8.36 million	Optionable
TMCI Treace Medical Concepts	250	65.04 million	49.80 million	Optionable

TMCI, BVS, IRMD, and INMD Headlines

Recent News About These Companies

Treace Medical (TMCI) Q2 2026 Earnings Call Transcript

August 14 at 5:35 PM | finance.yahoo.com

Truist Financial Increases Treace Medical Concepts (NASDAQ:TMCI) Price Target to $5.00

August 12 at 1:06 AM | americanbankingnews.com

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Rating of "Reduce" by Analysts

August 11, 2026 | marketbeat.com

Treace Medical Concepts (NASDAQ:TMCI) Price Target Raised to $5.00 at Truist Financial

August 10, 2026 | marketbeat.com

Treace Medical Concepts, Inc. Q2 2026 Earnings Call Summary

August 8, 2026 | finance.yahoo.com

Treace Medical Concepts (NASDAQ:TMCI) Posts Quarterly Earnings Results, Beats Estimates By $0.06 EPS

August 7, 2026 | marketbeat.com

Treace Medical Concepts: Q2 Earnings Snapshot

August 7, 2026 | seattlepi.comS

Treace Medical Concepts, Inc. (TMCI) Q2 2026 Earnings Call Transcript

August 7, 2026 | seekingalpha.com

Treace Medical Concepts Q2 Earnings Call Highlights

August 7, 2026 | marketbeat.com

Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates

August 7, 2026 | zacks.com

Treace Medical Concepts Reports Second Quarter 2026 Financial Results

August 7, 2026 | globenewswire.com

Treace Medical Concepts (TMCI) Expected to Post Earnings on Friday

July 31, 2026 | marketbeat.com

Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

July 24, 2026 | prnewswire.com

Treace to Report Second Quarter 2026 Financial Results on August 7, 2026

July 24, 2026 | globenewswire.com

Why Treace Medical Concepts, Inc.’s (TMCI) Stock Is Down 5.42%

July 23, 2026 | aaii.comA

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Recommendation of "Reduce" from Brokerages

July 17, 2026 | marketbeat.com

Treace Medical Concepts (NASDAQ:TMCI) Given New $4.00 Price Target at Truist Financial

July 16, 2026 | marketbeat.com

Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Treace Medical Concepts, Inc. (TMCI)

July 13, 2026 | globenewswire.com

TMCI Share News Today

June 30, 2026 | uk.investing.com

Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System

June 18, 2026 | globenewswire.com

Treace Medical Concepts (NASDAQ:TMCI) CEO John Treace Buys 22,887 Shares

June 12, 2026 | insidertrades.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMCI, BVS, IRMD, and INMD Company Descriptions

Bioventus NASDAQ:BVS

$14.26 +0.37 (+2.66%)

Closing price 08/14/2026 04:00 PM Eastern

Extended Trading

$14.30 +0.04 (+0.29%)

As of 08/14/2026 07:59 PM Eastern

Bioventus Inc. a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's portfolio of products includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions include bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies comprise an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

InMode NASDAQ:INMD

$15.15 -0.05 (-0.33%)

Closing price 08/14/2026 04:00 PM Eastern

Extended Trading

$15.16 +0.00 (+0.03%)

As of 08/14/2026 04:10 PM Eastern

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

iRadimed NASDAQ:IRMD

$86.95 -0.21 (-0.24%)

Closing price 08/14/2026 04:00 PM Eastern

Extended Trading

$87.02 +0.08 (+0.09%)

As of 08/14/2026 07:34 PM Eastern

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

Treace Medical Concepts NASDAQ:TMCI

$4.79 +0.28 (+6.21%)

Closing price 08/14/2026 04:00 PM Eastern

Extended Trading

$4.78 0.00 (-0.10%)

As of 08/14/2026 07:34 PM Eastern

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TMCI, BVS, IRMD, and INMD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TMCI, BVS, IRMD, and INMD Earnings

Compare Dividends

Latest TMCI, BVS, IRMD, and INMD Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TMCI, BVS, IRMD, and INMD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMCI, BVS, IRMD, and INMD Company Descriptions

Bioventus NASDAQ:BVS

InMode NASDAQ:INMD

iRadimed NASDAQ:IRMD

Treace Medical Concepts NASDAQ:TMCI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TMCI, BVS, IRMD, and INMD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TMCI, BVS, IRMD, and INMD Earnings

Compare Dividends

Latest TMCI, BVS, IRMD, and INMD Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TMCI, BVS, IRMD, and INMD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMCI, BVS, IRMD, and INMD Company Descriptions

Bioventus NASDAQ:BVS

InMode NASDAQ:INMD

iRadimed NASDAQ:IRMD

Treace Medical Concepts NASDAQ:TMCI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools